Position Papers

On Horizon2020

Towards a European Strategy for Medicines Research (2014–2020): The EUFEPS Position Paper on Horizon 2020; R. Gaspar, B. Aksu, A. Cuine, M. Danhof, M. Jadrijevic-Mladar Takac, H.H. Lindén, A. Link, E.M. Muchitsch, C.G. Wilson, P. Öhrngren, L. Dencker; European Journal of Pharmaceutical Sciences, 2012, 47, 979–987; DOI: 10.1016/j.ejps.2012.09.020

Abstract

 

On PGPGP
5th Anniversary Meeting of the European Research Network Pharmacogenetics/Pharmacogenomics; J.C. Fox, A. Daly, I. Cascorbi, A. Alfirevic, H.H. Lindén and A.H. Maitland-van der Zee; Pharmacogenomics, 2012, 13(7), 747–749; DOI: 10.2217/PGS.12.43

 

On QbD & PAT
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT); B. Aksu, T. de Beer, S. Folestad, J. Ketolainen, H.H. Lindén, J. Almeida Lopes, M. de Matas, W. Oostra, J. Rantanen, M. Weimer; European Journal of Pharmaceutical Sciences, 2012, 47, 402–405; DOI: 10.1016/j.ejps.2012.06.009

Abstract